Résumé
To assess the safety and efficacy of a new neoadjuvant chemoradiation (CRT) docetaxel-based regimen in patients with resectable adenocarcinoma of the pancreatic head or body.
- Titre
- Neoadjuvant Docetaxel-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreas
- Créateurs - sans rôle
- Olivier Turrini - Department of Surgical OncologyMarc Ychou - Department of Medical OncologyLaurence Moureau-Zabotto - Département de RadiothérapiePhilippe Rouanet - Department of Surgical OncologyMarc Giovannini - Department of EndoscopyVincent Moutardier - Department of Surgical OncologyDavid Azria - Department of RadiotherapyJean-Robert Delpero - Department of Surgical OncologyFrédéric Viret - Department of Medical Oncology
- Détails de publication
- European journal of surgical oncology, Vol.36(10)
- Éditeur
- WB Saunders
- Identifiants
- 99140138509311
- Unité académique
- Institut de Recherche en Cancérologie de Montpellier - IRCM; Recherche hors université
- Langue
- English
- Type de ressource
- Journal article